Ocular Sarcoidosis

  • Kalpana Babu


Sarcoidosis is a chronic multisystemic granulomatous disorder caused by an exaggerated cellular immune response to a variety of self- or non-self-antigens in a genetically predisposed individual. It is characterized by noncaseating granulomas affecting many organs including the lung, lymph nodes, skin, heart, liver, muscles, and eye [1, 2]. The diagnosis of sarcoidosis is usually made on the basis of a biopsy and a combination of typical clinical features and radiology findings in the absence of any condition that can cause similar clinicoradiological and pathological changes.


Lacrimal Gland Cystoid Macular Edema Cardiac Sarcoidosis Ocular Involvement Fluocinolone Acetonide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med. 1997;336:1223–34.CrossRefGoogle Scholar
  2. 2.
    Rothova A. Ocular involvement in sarcoidosis. Br J Ophthalmol. 2000;84:110–6.PubMedCentralCrossRefPubMedGoogle Scholar
  3. 3.
    Schumacher G. Fall von beiderseitiger iridocyclitis chronica bei boeckschem multiplem benignem sarkoid. Munch Med Wochenschr. 1909;56:2664.Google Scholar
  4. 4.
    Usui Y, Kaiser ED, See RF, Rao NA, Sharma OP. Update of ocular manifestations in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2002;19(3):167–75.PubMedGoogle Scholar
  5. 5.
    Jones N, Mochizuki M. Sarcoidosis: epidemiology and clinical features. Ocul Immunol Inflamm. 2010;18(2):72–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Rothova A, Alberts C, Glasius E, et al. Risk factors for ocular sarcoidosis. Doc Ophthalmol. 1989;72:287–96.CrossRefPubMedGoogle Scholar
  7. 7.
    Hunter DG, Foster CS. Ocular manifestations of sarcoidosis. In: Albert DM, Jakobiec FA, editors. Principles and practice of ophthalmology. Philadelphia: WB Saunders; 1994. p. 443–50.Google Scholar
  8. 8.
    Babu K, Kini R, Mehta R, Abraham MP, Subbakrishna DK, Murthy KR. Clinical profile of ocular sarcoidosis in a south Indian patient population. Ocul Immunol Inflamm. 2010;18(5):362.CrossRefPubMedGoogle Scholar
  9. 9.
    Pathanipitoon K, Goossens JHM, Tilborg TCV, Kunavisarut P, Choovuthayakorn J, Rothova A. Ocular sarcoidosis in Thailand. Eye. 2010;24:1669–74.CrossRefGoogle Scholar
  10. 10.
    Chan A, Sharma OP, Rao NA. Review for disease of the year: immunopathogenesis of ocular sarcoidosis. Ocul Immunol Inflamm. 2010;18(3):143–51.CrossRefPubMedGoogle Scholar
  11. 11.
    Song Z, Marzilli L, Greenlee BM, et al. Mycobacterial catalase peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med. 2005;201(5):755–67.PubMedCentralCrossRefPubMedGoogle Scholar
  12. 12.
    Grunewald J. Genetics of sarcoidosis. Curr Opin Pulm Med. 2008;14(5):434–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Kojima K, Maruyama K, Inaba T, Nagata K, Yasuhara T, Yoneda K, Sugita S, Mochizuki M, Kinoshita S. The CD4/CD8 ratio in vitreous fluid is of high diagnostic value in sarcoidosis. Ophthalmology. 2012;119(11):2386–92.CrossRefPubMedGoogle Scholar
  14. 14.
    Biswas J, Krishnakumar S, Raghavendran R, Mahesh L. Lid swelling and diplopia as presenting features of orbital sarcoid. Indian J Ophthalmol. 2000;48(3):231–3.PubMedGoogle Scholar
  15. 15.
    Babu K, Kini R, Mehta R. Scleral nodule and bilateral disc edema as a presenting manifestation of systemic sarcoidosis. Ocul Immunol Inflamm. 2010;18(3):158–61.CrossRefPubMedGoogle Scholar
  16. 16.
    Verma A, Biswas J. Choroidal granuloma as an initial manifestation of systemic sarcoidosis. Int Ophthalmol. 2010;30(5):603–6.CrossRefPubMedGoogle Scholar
  17. 17.
    Herbort CP, Mochizuki M, Rao NA. International criteria for the diagnosis of ocular sarcoidosis: results of the first international workshop on ocular sarcoidosis (IWOS). Ocul Immunol Inflamm. 2009;17:160–9.CrossRefPubMedGoogle Scholar
  18. 18.
    Kawaguchi T, Hanada A, Horie S, et al. Evaluation of characteristic ocular signs and systemic investigations in ocular sarcoidosis patients. Jpn J Ophthalmol. 2007;51:121–6.CrossRefPubMedGoogle Scholar
  19. 19.
    Papadia M, Herbort CP, Mochizuki M. Diagnosis of ocular sarcoidosis. Ocul Immunol Inflamm. 2010;18(6):432–41.CrossRefPubMedGoogle Scholar
  20. 20.
    Birnbaum AD, Chakrabarti A, Tessler H, Goldstein DA. Clinical features and diagnostic evaluation of biopsy proven ocular sarcoidosis. Arch Ophthalmol. 2011;129(4):409–13.CrossRefPubMedGoogle Scholar
  21. 21.
    Mochizuki M, Takase H. The role of imaging in the diagnosis and management of ocular sarcoidosis. Int Ophthalmol Clin. 2012;52(4):113–20.CrossRefPubMedGoogle Scholar
  22. 22.
    Jindal SK, Gupta D, Aggarwal AN. Sarcoidosis in developing countries. Curr Opin Pulm Med. 2000;6:448–50.CrossRefPubMedGoogle Scholar
  23. 23.
    Smith-Rohrberg D, Sharma SK. Tuberculin skin test among pulmonary sarcoidosis patients with and without tuberculosis: its utility for the screening of the two conditions in tuberculosis-endemic regions. Sarcoidosis Vasc Diffuse Lung Dis. 2006;23(2):130–4.PubMedGoogle Scholar
  24. 24.
    Ganesh SK, Roopleen, Biswas J, Veena N. Role of high-resolution computerized tomography (HRCT) of the chest in granulomatous uveitis: a tertiary uveitis clinic experience from India. Ocul Immunol Inflamm. 2011;19(1):51–7.CrossRefPubMedGoogle Scholar
  25. 25.
    Agarwal R, Aggarwal AN, Gupta D. Efficacy and safety of conventional TBNA in sarcoidosis: a systematic review and meta-analysis. Respir Care. 2013;58:683–93.PubMedGoogle Scholar
  26. 26.
    Cowan CL. Differential diagnosis of ocular sarcoidosis. Ocul Immunol Inflamm. 2010;18(6):442–51.CrossRefPubMedGoogle Scholar
  27. 27.
    Shabbir Shafiq J, Biswas J. Optic nerve head sarcoid granuloma treated with intravenous methyl prednisolone. Oman J Ophthalmol. 2008;1(1):28–31.CrossRefGoogle Scholar
  28. 28.
    Baughman RP, Lower EE, Ingledue R, Kaufman AH. Management of ocular sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2012;29(1):26–33.PubMedGoogle Scholar
  29. 29.
    Bhat P, Cervantes-Castañeda RA, Doctor PP, Anzaar F, Foster CS. Mycophenolate mofetil therapy for sarcoidosis-associated uveitis. Ocul Immunol Inflamm. 2009;17(3):185–90.CrossRefPubMedGoogle Scholar
  30. 30.
    Lower EE, Baughman RP, Kaufman AH. Rituximab for refractory granulomatous eye disease. Clin Ophthalmol. 2012;6:1613–8.PubMedCentralPubMedGoogle Scholar

Copyright information

© Springer India 2016

Authors and Affiliations

  1. 1.Vittala International Institute of OphthalmologyPrabha Eye Clinic & Research CentreBangaloreIndia

Personalised recommendations